| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.082 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.058 | 0.4 |